MeredithLaRoseMD

PubMed

• Beyond BRCA: Diagnosis and management of homologous recombination repair deficient pancreatic cancer.
  Meredith LaRose, Gulam A Manji, Susan E Bates> ;Seminars in Oncology. 2023 Nov 24
• 53 citations
  Bridging Radiation Therapy Before Commercial Chimeric Antigen Receptor T-Cell Therapy for Relapsed or Refractory Aggressive B-Cell Lymphoma
  Christopher M. Wright, Michael J. LaRiviere, Jonathan Baron, C.Z. Uche, Ying Xiao, W. Tristram Arscott, Emily J. Anstadt, Andrew R. Barsky, David Miller, Meredith I. L...> ;International Journal of Radiation Oncology, Biology, Physics. 2020 Sep 1
• 21 citations
  Macrophage Migration Inhibitory Factor Is Detrimental in Pneumococcal Pneumonia and a Target for Therapeutic Immunomodulation
  Jeffrey N. Weiser, Aoife M. Roche, Christopher B. Hergott, Meredith I. LaRose, Tarah M. Connolly, William L. Jorgensen, Lin Leng, Richard Bucala, Rituparna Das> ;The Journal of Infectious Diseases. 2015 May 5
• 25 citations
  Macrophage Migration Inhibitory Factor Promotes Clearance of Pneumococcal Colonization
  Rituparna Das, Meredith I. LaRose, Christopher B. Hergott, Lin Leng, Richard Bucala, Jeffrey N. Weiser> ;Journal of Immunology. 2014 Jul 15
• Join now to see all

Abstracts/Posters

• Hospitalization Patterns with Commercial CAR T-Cell Therapy: A Single Institution Experience
  Meredith I LaRose, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Use of Bendamustine for Lymphodepletion before Tisagenlecleucel (anti-CD19 CAR T cells) for Aggressive B-Cell Lymphomas
  Meredith I LaRose, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019